loading
前日終値:
$53.16
開ける:
$52.56
24時間の取引高:
1.97M
Relative Volume:
1.44
時価総額:
$8.29B
収益:
$700.35M
当期純損益:
$461.90M
株価収益率:
18.88
EPS:
2.8696
ネットキャッシュフロー:
$-14.19M
1週間 パフォーマンス:
+0.37%
1か月 パフォーマンス:
-3.27%
6か月 パフォーマンス:
+46.72%
1年 パフォーマンス:
+61.75%
1日の値動き範囲:
Value
$51.83
$55.80
1週間の範囲:
Value
$51.83
$55.80
52週間の値動き範囲:
Value
$26.76
$59.30

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
名前
Tg Therapeutics Inc
Name
セクター
Healthcare (1052)
Name
電話
(212) 554-4484
Name
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
職員
399
Name
Twitter
@TGTherapeutics
Name
次回の収益日
2026-11-02
Name
最新のSEC提出書
Name
TGTX's Discussions on Twitter

Compare TGTX vs VRTX, REGN, MRNA, ARGX, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TGTX icon
TGTX
Tg Therapeutics Inc
54.17 8.29B 700.35M 461.90M -14.19M 2.8696
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
523.93 132.80B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
805.02 82.88B 14.92B 4.42B 3.79B 41.04
MRNA icon
MRNA
Moderna Inc
200.10 79.89B 2.23B -3.19B -1.60B -8.1462
ARGX icon
ARGX
Argen X Se Adr
873.71 54.94B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
377.63 42.72B 5.76B 514.49M 1.10B 4.4813

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-06 再開されました H.C. Wainwright Buy
2025-07-10 再開されました Goldman Neutral
2024-10-29 開始されました TD Cowen Buy
2023-08-02 アップグレード Goldman Sell → Neutral
2023-06-26 再開されました Jefferies Buy
2022-05-20 開始されました BofA Securities Underperform
2022-02-23 繰り返されました B. Riley Securities Buy
2021-11-15 ダウングレード Goldman Neutral → Sell
2021-04-20 開始されました Goldman Neutral
2021-04-19 繰り返されました H.C. Wainwright Buy
2020-09-01 開始されました JP Morgan Overweight
2020-08-11 繰り返されました H.C. Wainwright Buy
2020-06-05 開始されました Evercore ISI Outperform
2020-01-17 繰り返されました H.C. Wainwright Buy
2019-11-27 再開されました B. Riley FBR Buy
2019-02-06 再開されました Jefferies Buy
2018-09-25 ダウングレード Raymond James Strong Buy → Outperform
2018-03-09 繰り返されました B. Riley FBR, Inc. Buy
2017-12-01 再開されました B. Riley FBR, Inc. Buy
2017-11-14 再開されました H.C. Wainwright Buy
2017-04-25 開始されました Jefferies Buy
2017-03-06 繰り返されました FBR & Co. Outperform
2016-10-06 再開されました Brean Capital Buy
2016-05-27 開始されました SunTrust Buy
2015-12-01 開始されました FBR Capital Outperform
2015-09-09 開始されました Raymond James Strong Buy
2015-08-12 再開されました H.C. Wainwright Buy
2015-06-19 繰り返されました Brean Capital Buy
2014-12-11 繰り返されました ROTH Capital Buy
2014-12-10 繰り返されました ROTH Capital Buy
すべてを表示

Tg Therapeutics Inc (TGTX) 最新ニュース

pulisher
Oct 23, 2026

Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research

Oct 23, 2026
pulisher
Oct 21, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 21, 2026
pulisher
Oct 21, 2026

TG Therapeutics (TGTX) Showcases Long-Term MS Trial Data and Adv - GuruFocus

Oct 21, 2026
pulisher
Oct 21, 2026

TG Therapeutics reports seven-year BRIUMVI disability and safety findings - Mugglehead Investment Magazine

Oct 21, 2026
pulisher
Oct 21, 2026

TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026 - TG Therapeutics

Oct 21, 2026
pulisher
Oct 21, 2026

TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026 - Business Wire

Oct 21, 2026
pulisher
Oct 17, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 17, 2026
pulisher
Oct 13, 2026

TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - Zacks Investment Research

Oct 13, 2026
pulisher
Oct 13, 2026

TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView

Oct 13, 2026
pulisher
Oct 13, 2026

Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

Oct 13, 2026
pulisher
Oct 12, 2026

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - BioSpace

Oct 12, 2026
pulisher
Oct 12, 2026

TG Therapeutics (TGTX) Reports Five-Year Study Showing BRIUMVI's - GuruFocus

Oct 12, 2026
pulisher
Oct 12, 2026

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - Business Wire

Oct 12, 2026
pulisher
Oct 12, 2026

High Growth Tech Stocks To Watch In US October 2026 - Simply Wall Street

Oct 12, 2026
pulisher
Oct 12, 2026

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis - TG Therapeutics

Oct 12, 2026
pulisher
Oct 09, 2026

How TG’s MS Data Wave At MSToronto2026 At TG Therapeutics (TGTX) Has Changed Its Investment Story - Yahoo Finance

Oct 09, 2026
pulisher
Oct 08, 2026

TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow - Yahoo Finance

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - BioSpace

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics (TGTX) to Present Phase 1 Azer-cel Data and BRIU - GuruFocus

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - Business Wire

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 - TG Therapeutics

Oct 08, 2026
pulisher
Oct 08, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 08, 2026
pulisher
Oct 06, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Singapore

Oct 06, 2026
pulisher
Oct 05, 2026

TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech - ChartMill

Oct 05, 2026
pulisher
Oct 05, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 05, 2026
pulisher
Oct 02, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia

Oct 02, 2026
pulisher
Oct 01, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo Finance

Oct 01, 2026
pulisher
Sep 30, 2026

TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance Australia

Sep 30, 2026
pulisher
Sep 29, 2026

After tax other income/expense of TG Therapeutics, Inc. – HAN:NKB2 - TradingView

Sep 29, 2026
pulisher
Sep 29, 2026

TG Therapeutics, Inc. Revenue Breakdown – HAN:NKB2 - TradingView

Sep 29, 2026
pulisher
Sep 28, 2026

Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm - Morningstar

Sep 28, 2026
pulisher
Sep 28, 2026

TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions - Simply Wall Street

Sep 28, 2026
pulisher
Sep 23, 2026

TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 23, 2026

TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 21, 2026

TG Therapeutics (NASDAQ:TGTX) Combines Strong Growth With a Tight Technical Breakout Setup - ChartMill

Sep 21, 2026
pulisher
Sep 21, 2026

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 22.59% Upside Potential in the Biotech Sector - DirectorsTalk Interviews

Sep 21, 2026
pulisher
Sep 19, 2026

TG Therapeutics Inc (TGTX) Stock Price Today: $56.87 - Pluang

Sep 19, 2026
pulisher
Sep 18, 2026

TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History - benzinga.com

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - Yahoo Finance

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics Eyes $1B Run Rate as BRIUMVI Gains MS Market Share - TradingView

Sep 18, 2026
pulisher
Sep 18, 2026

TG Therapeutics (TGTX) Could Be 19% Undervalued After Its Recent Rebound - Yahoo Finance

Sep 18, 2026
pulisher
Sep 11, 2026

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

Sep 11, 2026
pulisher
Sep 10, 2026

TG Therapeutics (NASDAQ: TGTX) director plans $274,794.08 stock sale - Stock Titan

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference | TGTX Stock News - quiverquant.com

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - TG Therapeutics

Sep 10, 2026
pulisher
Sep 10, 2026

TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire

Sep 10, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com India

Sep 09, 2026
pulisher
Sep 09, 2026

TG Therapeutics at Cantor conference: briumvi gains momentum By Investing.com - Investing.com UK

Sep 09, 2026

Tg Therapeutics Inc (TGTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Tg Therapeutics Inc (TGTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Charney Laurence N
Director
Sep 10 '26
Proposed Sale
54.96
5,000
274,794
0
Echelard Yann
Director
Nov 24 '25
Sale
32.57
5,000
162,850
223,816
Echelard Yann
Director
Nov 24 '25
Proposed Sale
32.57
5,000
162,850
0
$58.02
price down icon 0.58%
$90.33
price down icon 2.17%
$61.23
price down icon 1.76%
$8.22
price down icon 1.08%
$88.01
price down icon 2.46%
$138.43
price down icon 0.79%
大文字化:     |  ボリューム (24 時間):